Investigation summary: bd received 1 representative sample submitted for evaluation.
The reported issue was confirmed upon testing of the sample.
During internal flow testing, the sample was occluded.
Further examination showed that excess medical grade silicone from our lubrication process was found within the cannula.
The excess was stuck to the needle, clogging the cannula, resulting in occlusion.
A device history record review showed no non-conformance's associated with this issue during the production of this batch.
A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.
Corrective actions have been initiated and a manufacturing root cause has been identified.
Actions have been made to address the issue.
Complaints received for this device and reported condition will continue to be tracked and trended.
Information will be captured on trend reports and monitored.
Our business team regularly reviews the collected data for identification of emerging trends.
|
It was reported that 30 bd saf-t-intima¿ iv catheter safety systems' needles were occluded with excess silicone.
The following information was provided by the initial reporter, translated from (b)(6) to english: "the indwelling needle couldn't exhaust when it was connected with infusion set" via bd investigation: "during internal flow testing, the sample was occluded.
Further examination showed that excess medical grade silicone from our lubrication process was found within the cannula.
The excess was stuck to the needle, clogging the cannula, resulting in occlusion.
".
|